Role of ICT and eHealth in diabetic pregnancy

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Role of ICT and eHealth in diabetic pregnancy Pregnant women with diabetes require frequent contact with their clinicians in an attempt to achieve normoglycaemia. With increasing numbers of women diagnosed with diabetes in pregnancy, particularly gestational diabetes, the demand on health services and the budgetary impact, particularly on health care practitioner time, will be significant. Healthcare resources are finite so it is incumbent on the clinical and research community to develop programmes which can deliver healthcare more effectively and efficiently. eHealth has been proposed as a potential solution which could minimise the burden of disease on health-care providers, and the system as a whole, while at the same time increasing access to and efficiency of care. eHealth is the use of information and communication technologies (ICT) for health and is one of the most rapidly growing areas in health today. eHealth includes infrastructural arrangements such as regional health networks and electronic patient records systems as well as telemedicine. Telemedicine literally translated means “healing at a distance”. Rather than being a single technology, telemedicine is part of a wider process or chain of care. Its distinguishing feature is the reliance on ICT as a substitute for personal contact between participants. Telemedicine covers a wide range of activities including diagnosis, treatment and prevention of disease and injuries, research and evaluation and education of health care providers. There are numerous telemedicine programmes worldwide covering virtually every medical speciality. Most serve people in rural areas or the elderly in their homes.In the care of those with diabetes telemedicine has been used for retinopathy screening, patient education, ulcer management and interventions to improve diet, increase physical activity and encourage weight loss. The most frequent use of telemedicine in diabetes however has been for the transmission of blood glucose values from the patient to their health care provider. Telemedicine tends to be used in this way in an attempt to improve the impact of self-monitoring of blood glucose (SMBG), to make SMBG more compatible with the patient’s lifestyle and to engage patients more in their own care. As per telemedicine in diabetes generally, the most common use for telemedicine in pregnancy affected by diabetes has been for transmission of SMBG values. This has been done with the aim of facilitating increased frequency of review, reducing the need for such frequent face-to-face review and enabling faster transmission of SMBG values to the health care team. This presentation will set the scene relating to the use of telemedicine in diabetic pregnancy. It will discuss the findings from Tele-Mum1, a feasibility study for a randomised controlled trial, conducted to determine the feasibility and acceptability of using telemedicine in the diabetes care of those with gestational diabetes and to ultimately replace alternate diabetes review clinics with telemedicine review. Patient and staff perspectives of using telemedicine will be discussed along with the broader challenges encountered when implementing and evaluating telemedicine services. As this was a feasibility study it was not powered to detect significant differences however, the process of study set up, staff training, engagement with industry and multi-site trial design led to considerable learning and insight in addition to the measured outcomes. Conclusions to be raised as discussion points include that; the women in the study were pleased to able to reduce clinic attendance through tele-monitoring but were also reassured that face-to-face contact was still available as a ‘safety net’, that in rural areas the ICT infrastructure may not be sufficiently reliable to support remote monitoring, that the devices and services offered by industry are rapidly changing and gathering evidence to support their application in practice is a challenge not least due to ambiguity surrounding identification of the most appropriate outcome measures. While eHealth can make a valuable contribution to the management of diabetic pregnancy it should not be viewed as a simple, cheap, panacea to overcome all the issues raised in the introduction.
LanguageEnglish
Title of host publicationUnknown Host Publication
Number of pages1
Publication statusAccepted/In press - 4 Sep 2017
EventInternational Diabetes Federation - IDF 2017 Abu Dhabi - Abu Dhabi
Duration: 4 Sep 2017 → …

Conference

ConferenceInternational Diabetes Federation - IDF 2017 Abu Dhabi
Period4/09/17 → …

Fingerprint

Pregnancy in Diabetics
Telemedicine
Communication
Technology
Blood Glucose Self-Monitoring
Health Personnel
Delivery of Health Care
Gestational Diabetes
Feasibility Studies
Industry

Keywords

  • Diabetic pregnancy
  • ICT
  • eHealth
  • Tele-Mum

Cite this

Given, J. (Accepted/In press). Role of ICT and eHealth in diabetic pregnancy. In Unknown Host Publication
@inproceedings{8d7cfd1caa2a4200b44ebff774c63f51,
title = "Role of ICT and eHealth in diabetic pregnancy",
abstract = "Role of ICT and eHealth in diabetic pregnancy Pregnant women with diabetes require frequent contact with their clinicians in an attempt to achieve normoglycaemia. With increasing numbers of women diagnosed with diabetes in pregnancy, particularly gestational diabetes, the demand on health services and the budgetary impact, particularly on health care practitioner time, will be significant. Healthcare resources are finite so it is incumbent on the clinical and research community to develop programmes which can deliver healthcare more effectively and efficiently. eHealth has been proposed as a potential solution which could minimise the burden of disease on health-care providers, and the system as a whole, while at the same time increasing access to and efficiency of care. eHealth is the use of information and communication technologies (ICT) for health and is one of the most rapidly growing areas in health today. eHealth includes infrastructural arrangements such as regional health networks and electronic patient records systems as well as telemedicine. Telemedicine literally translated means “healing at a distance”. Rather than being a single technology, telemedicine is part of a wider process or chain of care. Its distinguishing feature is the reliance on ICT as a substitute for personal contact between participants. Telemedicine covers a wide range of activities including diagnosis, treatment and prevention of disease and injuries, research and evaluation and education of health care providers. There are numerous telemedicine programmes worldwide covering virtually every medical speciality. Most serve people in rural areas or the elderly in their homes.In the care of those with diabetes telemedicine has been used for retinopathy screening, patient education, ulcer management and interventions to improve diet, increase physical activity and encourage weight loss. The most frequent use of telemedicine in diabetes however has been for the transmission of blood glucose values from the patient to their health care provider. Telemedicine tends to be used in this way in an attempt to improve the impact of self-monitoring of blood glucose (SMBG), to make SMBG more compatible with the patient’s lifestyle and to engage patients more in their own care. As per telemedicine in diabetes generally, the most common use for telemedicine in pregnancy affected by diabetes has been for transmission of SMBG values. This has been done with the aim of facilitating increased frequency of review, reducing the need for such frequent face-to-face review and enabling faster transmission of SMBG values to the health care team. This presentation will set the scene relating to the use of telemedicine in diabetic pregnancy. It will discuss the findings from Tele-Mum1, a feasibility study for a randomised controlled trial, conducted to determine the feasibility and acceptability of using telemedicine in the diabetes care of those with gestational diabetes and to ultimately replace alternate diabetes review clinics with telemedicine review. Patient and staff perspectives of using telemedicine will be discussed along with the broader challenges encountered when implementing and evaluating telemedicine services. As this was a feasibility study it was not powered to detect significant differences however, the process of study set up, staff training, engagement with industry and multi-site trial design led to considerable learning and insight in addition to the measured outcomes. Conclusions to be raised as discussion points include that; the women in the study were pleased to able to reduce clinic attendance through tele-monitoring but were also reassured that face-to-face contact was still available as a ‘safety net’, that in rural areas the ICT infrastructure may not be sufficiently reliable to support remote monitoring, that the devices and services offered by industry are rapidly changing and gathering evidence to support their application in practice is a challenge not least due to ambiguity surrounding identification of the most appropriate outcome measures. While eHealth can make a valuable contribution to the management of diabetic pregnancy it should not be viewed as a simple, cheap, panacea to overcome all the issues raised in the introduction.",
keywords = "Diabetic pregnancy, ICT, eHealth, Tele-Mum",
author = "Joanne Given",
note = "Invited speaker Reference text: 1. Given JE, Bunting BP, O’Kane MJ, et al. (2015) Tele-Mum: A Feasibility Study for a Randomized Controlled Trial Exploring the Potential for Telemedicine in the Diabetes Care of Those with Gestational Diabetes. Diabetes Technology & Therapeutics, 17(12): 880–888.",
year = "2017",
month = "9",
day = "4",
language = "English",
booktitle = "Unknown Host Publication",

}

Given, J 2017, Role of ICT and eHealth in diabetic pregnancy. in Unknown Host Publication. International Diabetes Federation - IDF 2017 Abu Dhabi, 4/09/17.

Role of ICT and eHealth in diabetic pregnancy. / Given, Joanne.

Unknown Host Publication. 2017.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

TY - GEN

T1 - Role of ICT and eHealth in diabetic pregnancy

AU - Given, Joanne

N1 - Invited speaker Reference text: 1. Given JE, Bunting BP, O’Kane MJ, et al. (2015) Tele-Mum: A Feasibility Study for a Randomized Controlled Trial Exploring the Potential for Telemedicine in the Diabetes Care of Those with Gestational Diabetes. Diabetes Technology & Therapeutics, 17(12): 880–888.

PY - 2017/9/4

Y1 - 2017/9/4

N2 - Role of ICT and eHealth in diabetic pregnancy Pregnant women with diabetes require frequent contact with their clinicians in an attempt to achieve normoglycaemia. With increasing numbers of women diagnosed with diabetes in pregnancy, particularly gestational diabetes, the demand on health services and the budgetary impact, particularly on health care practitioner time, will be significant. Healthcare resources are finite so it is incumbent on the clinical and research community to develop programmes which can deliver healthcare more effectively and efficiently. eHealth has been proposed as a potential solution which could minimise the burden of disease on health-care providers, and the system as a whole, while at the same time increasing access to and efficiency of care. eHealth is the use of information and communication technologies (ICT) for health and is one of the most rapidly growing areas in health today. eHealth includes infrastructural arrangements such as regional health networks and electronic patient records systems as well as telemedicine. Telemedicine literally translated means “healing at a distance”. Rather than being a single technology, telemedicine is part of a wider process or chain of care. Its distinguishing feature is the reliance on ICT as a substitute for personal contact between participants. Telemedicine covers a wide range of activities including diagnosis, treatment and prevention of disease and injuries, research and evaluation and education of health care providers. There are numerous telemedicine programmes worldwide covering virtually every medical speciality. Most serve people in rural areas or the elderly in their homes.In the care of those with diabetes telemedicine has been used for retinopathy screening, patient education, ulcer management and interventions to improve diet, increase physical activity and encourage weight loss. The most frequent use of telemedicine in diabetes however has been for the transmission of blood glucose values from the patient to their health care provider. Telemedicine tends to be used in this way in an attempt to improve the impact of self-monitoring of blood glucose (SMBG), to make SMBG more compatible with the patient’s lifestyle and to engage patients more in their own care. As per telemedicine in diabetes generally, the most common use for telemedicine in pregnancy affected by diabetes has been for transmission of SMBG values. This has been done with the aim of facilitating increased frequency of review, reducing the need for such frequent face-to-face review and enabling faster transmission of SMBG values to the health care team. This presentation will set the scene relating to the use of telemedicine in diabetic pregnancy. It will discuss the findings from Tele-Mum1, a feasibility study for a randomised controlled trial, conducted to determine the feasibility and acceptability of using telemedicine in the diabetes care of those with gestational diabetes and to ultimately replace alternate diabetes review clinics with telemedicine review. Patient and staff perspectives of using telemedicine will be discussed along with the broader challenges encountered when implementing and evaluating telemedicine services. As this was a feasibility study it was not powered to detect significant differences however, the process of study set up, staff training, engagement with industry and multi-site trial design led to considerable learning and insight in addition to the measured outcomes. Conclusions to be raised as discussion points include that; the women in the study were pleased to able to reduce clinic attendance through tele-monitoring but were also reassured that face-to-face contact was still available as a ‘safety net’, that in rural areas the ICT infrastructure may not be sufficiently reliable to support remote monitoring, that the devices and services offered by industry are rapidly changing and gathering evidence to support their application in practice is a challenge not least due to ambiguity surrounding identification of the most appropriate outcome measures. While eHealth can make a valuable contribution to the management of diabetic pregnancy it should not be viewed as a simple, cheap, panacea to overcome all the issues raised in the introduction.

AB - Role of ICT and eHealth in diabetic pregnancy Pregnant women with diabetes require frequent contact with their clinicians in an attempt to achieve normoglycaemia. With increasing numbers of women diagnosed with diabetes in pregnancy, particularly gestational diabetes, the demand on health services and the budgetary impact, particularly on health care practitioner time, will be significant. Healthcare resources are finite so it is incumbent on the clinical and research community to develop programmes which can deliver healthcare more effectively and efficiently. eHealth has been proposed as a potential solution which could minimise the burden of disease on health-care providers, and the system as a whole, while at the same time increasing access to and efficiency of care. eHealth is the use of information and communication technologies (ICT) for health and is one of the most rapidly growing areas in health today. eHealth includes infrastructural arrangements such as regional health networks and electronic patient records systems as well as telemedicine. Telemedicine literally translated means “healing at a distance”. Rather than being a single technology, telemedicine is part of a wider process or chain of care. Its distinguishing feature is the reliance on ICT as a substitute for personal contact between participants. Telemedicine covers a wide range of activities including diagnosis, treatment and prevention of disease and injuries, research and evaluation and education of health care providers. There are numerous telemedicine programmes worldwide covering virtually every medical speciality. Most serve people in rural areas or the elderly in their homes.In the care of those with diabetes telemedicine has been used for retinopathy screening, patient education, ulcer management and interventions to improve diet, increase physical activity and encourage weight loss. The most frequent use of telemedicine in diabetes however has been for the transmission of blood glucose values from the patient to their health care provider. Telemedicine tends to be used in this way in an attempt to improve the impact of self-monitoring of blood glucose (SMBG), to make SMBG more compatible with the patient’s lifestyle and to engage patients more in their own care. As per telemedicine in diabetes generally, the most common use for telemedicine in pregnancy affected by diabetes has been for transmission of SMBG values. This has been done with the aim of facilitating increased frequency of review, reducing the need for such frequent face-to-face review and enabling faster transmission of SMBG values to the health care team. This presentation will set the scene relating to the use of telemedicine in diabetic pregnancy. It will discuss the findings from Tele-Mum1, a feasibility study for a randomised controlled trial, conducted to determine the feasibility and acceptability of using telemedicine in the diabetes care of those with gestational diabetes and to ultimately replace alternate diabetes review clinics with telemedicine review. Patient and staff perspectives of using telemedicine will be discussed along with the broader challenges encountered when implementing and evaluating telemedicine services. As this was a feasibility study it was not powered to detect significant differences however, the process of study set up, staff training, engagement with industry and multi-site trial design led to considerable learning and insight in addition to the measured outcomes. Conclusions to be raised as discussion points include that; the women in the study were pleased to able to reduce clinic attendance through tele-monitoring but were also reassured that face-to-face contact was still available as a ‘safety net’, that in rural areas the ICT infrastructure may not be sufficiently reliable to support remote monitoring, that the devices and services offered by industry are rapidly changing and gathering evidence to support their application in practice is a challenge not least due to ambiguity surrounding identification of the most appropriate outcome measures. While eHealth can make a valuable contribution to the management of diabetic pregnancy it should not be viewed as a simple, cheap, panacea to overcome all the issues raised in the introduction.

KW - Diabetic pregnancy

KW - ICT

KW - eHealth

KW - Tele-Mum

M3 - Conference contribution

BT - Unknown Host Publication

ER -

Given J. Role of ICT and eHealth in diabetic pregnancy. In Unknown Host Publication. 2017